U.S. Big Pharma, Big Dividends

Johnson & Johnson

Market Cap: US$374.4b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Merck

Market Cap: US$218.8b

Operates as a healthcare company worldwide.

Organon

Market Cap: US$3.8b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Bristol-Myers Squibb

Market Cap: US$120.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Zoetis

Market Cap: US$73.2b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Pfizer

Market Cap: US$140.1b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Perrigo

Market Cap: US$3.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Viatris

Market Cap: US$10.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.